Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator. Its exact mechanism of action is not fully understood but is believed to involve direct relaxation of vascular smooth muscle and possibly beta-adrenergic stimulation.
## Primary Indications
* Peripheral vascular disease (e.g., arteriosclerosis obliterans, intermittent claudication, Raynaud's disease).
## Adult Dosing
* **Usual dose:** 10 mg to 20 mg orally three to four times daily.
* **Maximum dose:** Not explicitly defined, but doses exceeding 20 mg per administration are generally not recommended.
## Pediatric Dosing
* Pediatric dosing is not established. Safety and efficacy have not been demonstrated in this population.
## Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment, as the drug is generally well-tolerated. However, caution may be advised in patients with severe disease.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Use in patients with congenital heart disease.
* Use in patients who have not been advised to use the drug by their physician for specific medical conditions.
## Adverse Effects
* **Common:** Hypotension, dizziness, lightheadedness, nausea, vomiting, weakness, flushing, abdominal distress, rash.
* **Serious:** Palpitations, chest pain, shortness of breath, paradoxical increase in angina symptoms.
## Key Drug Interactions
* **Antihypertensives:** May potentiate hypotensive effects. Monitor blood pressure closely.
* **Other vasodilators:** Additive hypotensive effects may occur.
## Monitoring
* Blood pressure: Monitor for hypotension.
* Symptomatic improvement: Assess effectiveness for the patient's specific condition.
* Adverse effects: Monitor for any new or worsening symptoms.
## Clinical Pearls
* The efficacy of isoxsuprine hydrochloride in peripheral vascular disease is controversial, and it is not approved by the FDA for this indication.
* Some sources suggest that isoxsuprine may be more effective when administered as a depot injection, but oral administration is more common.
* Patients should be advised to avoid driving or operating heavy machinery until they know how this medication affects them, due to potential dizziness and lightheadedness.
**Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for definitive guidance, as drug information can change.
